daiichi, ranbaxy, ranbaxy daiichi, daichi, ranbaxy news

Ranbaxy India is all set to sell 34.8 per cent stake in Ranbaxy Laboratories Ltd to the Japanese Pharma firm, Daiichi Sankyo Co. After buying the 34.8 per cent stake, Daiichi Sankyo will have to make a purchase offer of an additional 20% from the ordinary shareholders of Ranbaxy.

The deal will help Daiichi Sankyo to hold a controlling 51 per cent stake in Ranbaxy, the Indian Pharma company. The deal will cost Daiichi Sankyo $4.6B. It is the biggest takeover deal in the history of Indian pharma industry by an international company.

The promoters of Ranbaxy Pharma, Malvinder Singh and Shivinder Singh, will keep about 26 per cent stake in the firm but it would mean the complete exit of Ranbaxy promoters from the company.

This multi-billion Daiichi Sankyo- Ranbaxy deal created A positive MOOD in the market and as many as 863 shares have advanced.


Post a Comment